Sequent Medical, a privately-held venture backed medical device company founded in 2007, specializes in the development of catheter-based neurovascular technologies. Their proprietary Microbraid™ technology has led to the creation of the WEB™ Aneurysm Embolization System, a versatile option for treating ruptured and unruptured aneurysms. With the CE mark, the WEB has successfully treated nearly 600 aneurysms in Europe, Latin America, and New Zealand. However, it is not yet available for sale or use in the United States. Headquartered in Aliso Viejo, California, Sequent Medical also operates in Bonn, Germany.